Cross-sectional and longitudinal association of sleep and Alzheimer biomarkers in cognitively unimpaired adults

Sleep abnormalities are prevalent in Alzheimer's disease, with sleep quality already impaired at its preclinical stage. Epidemiological and experimental data point to sleep abnormalities contributing to the risk of Alzheimer's disease. However, previous studies are limited by either a lack...

Descripción completa

Detalles Bibliográficos
Autores: Blackman, Jonathan, Stankeviciute, Laura, Arenaza Urquijo, Eider M., Suárez Calvet, Marc, Sánchez Benavides, Gonzalo, Vilor Tejedor, Natalia, Iranzo, Alex, Molinuevo, José Luis, Gispert, Juan Domingo, Coulthard, Elizabeth, Grau Rivera, Oriol, European Prevention of Alzheimer’s Disease (EPAD) Consortium
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2022
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/209366
Acceso en línea:https://hdl.handle.net/2445/209366
Access Level:acceso abierto
Palabra clave:Programes de prevenció
Malaltia d'Alzheimer
Trastorns del son
Marcadors bioquímics
Prevention programs
Alzheimer's disease
Sleep disorders
Biochemical markers
id ES_1f0b1f2f9e5a1e480904d48bbf1fe9ba
oai_identifier_str oai:recercat.cat:2445/209366
network_acronym_str ES
network_name_str España
repository_id_str
spelling Cross-sectional and longitudinal association of sleep and Alzheimer biomarkers in cognitively unimpaired adultsBlackman, JonathanStankeviciute, LauraArenaza Urquijo, Eider M.Suárez Calvet, MarcSánchez Benavides, GonzaloVilor Tejedor, NataliaIranzo, AlexMolinuevo, José LuisGispert, Juan DomingoCoulthard, ElizabethGrau Rivera, OriolEuropean Prevention of Alzheimer’s Disease (EPAD) ConsortiumProgrames de prevencióMalaltia d'AlzheimerTrastorns del sonMarcadors bioquímicsPrevention programsAlzheimer's diseaseSleep disordersBiochemical markersSleep abnormalities are prevalent in Alzheimer's disease, with sleep quality already impaired at its preclinical stage. Epidemiological and experimental data point to sleep abnormalities contributing to the risk of Alzheimer's disease. However, previous studies are limited by either a lack of Alzheimer's disease biomarkers, reduced sample size or cross-sectional design. Understanding if, when, and how poor sleep contributes to Alzheimer's disease progression is important so that therapies can be targeted to the right phase of the disease. Using the largest cohort to date, the European Prevention of Alzheimer's Dementia Longitudinal Cohort Study, we test the hypotheses that poor sleep is associated with core Alzheimer's disease CSF biomarkers cross-sectionally and predicts future increments of Alzheimer's disease pathology in people without identifiable symptoms of Alzheimer's disease at baseline. This study included 1168 adults aged over 50 years with CSF core Alzheimer's disease biomarkers (total tau, phosphorylated tau and amyloid-beta), cognitive performance, and sleep quality (Pittsburgh sleep quality index questionnaire) data. We used multivariate linear regressions to analyse associations between core Alzheimer's disease biomarkers and the following Pittsburgh sleep quality index measures: total score of sleep quality, binarized score (poor sleep categorized as Pittsburgh sleep quality index > 5), sleep latency, duration, efficiency and disturbance. On a subsample of 332 participants with CSF taken at baseline and after an average period of 1.5 years, we assessed the effect of baseline sleep quality on change in Alzheimer's disease biomarkers over time. Cross-sectional analyses revealed that poor sleep quality (Pittsburgh sleep quality index total > 5) was significantly associated with higher CSF t-tau; shorter sleep duration (<7 h) was associated with higher CSF p-tau and t-tau; and a higher degree of sleep disturbance (1-9 versus 0 and >9 versus 0) was associated with lower CSF amyloid-beta. Longitudinal analyses showed that greater sleep disturbances (1-9 versus 0 and >9 versus 0) were associated with a decrease in CSF Aβ42 over time. This study demonstrates that self-reported poor sleep quality is associated with greater Alzheimer's disease-related pathology in cognitively unimpaired individuals, with longitudinal results further strengthening the hypothesis that disrupted sleep may represent a risk factor for Alzheimer's disease. This highlights the need for future work to test the efficacy of preventive practices, designed to improve sleep at pre-symptomatic stages of disease, on reducing Alzheimer's disease pathology.Oxford University Press2024202420222024info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion13 p.application/pdfhttps://hdl.handle.net/2445/209366Articles publicats en revistes (Medicina)reponame:Recercat. Dipósit de la Recerca de Catalunyainstname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)InglésReproducció del document publicat a: https://doi.org/10.1093/braincomms/fcac257Brain Communications, 2022, vol. 4, num.6https://doi.org/10.1093/braincomms/fcac257cc-by (c) Jonathan Blackman et al., 2022http://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:recercat.cat:2445/2093662026-05-29T05:05:01Z
dc.title.none.fl_str_mv Cross-sectional and longitudinal association of sleep and Alzheimer biomarkers in cognitively unimpaired adults
title Cross-sectional and longitudinal association of sleep and Alzheimer biomarkers in cognitively unimpaired adults
spellingShingle Cross-sectional and longitudinal association of sleep and Alzheimer biomarkers in cognitively unimpaired adults
Blackman, Jonathan
Programes de prevenció
Malaltia d'Alzheimer
Trastorns del son
Marcadors bioquímics
Prevention programs
Alzheimer's disease
Sleep disorders
Biochemical markers
title_short Cross-sectional and longitudinal association of sleep and Alzheimer biomarkers in cognitively unimpaired adults
title_full Cross-sectional and longitudinal association of sleep and Alzheimer biomarkers in cognitively unimpaired adults
title_fullStr Cross-sectional and longitudinal association of sleep and Alzheimer biomarkers in cognitively unimpaired adults
title_full_unstemmed Cross-sectional and longitudinal association of sleep and Alzheimer biomarkers in cognitively unimpaired adults
title_sort Cross-sectional and longitudinal association of sleep and Alzheimer biomarkers in cognitively unimpaired adults
dc.creator.none.fl_str_mv Blackman, Jonathan
Stankeviciute, Laura
Arenaza Urquijo, Eider M.
Suárez Calvet, Marc
Sánchez Benavides, Gonzalo
Vilor Tejedor, Natalia
Iranzo, Alex
Molinuevo, José Luis
Gispert, Juan Domingo
Coulthard, Elizabeth
Grau Rivera, Oriol
European Prevention of Alzheimer’s Disease (EPAD) Consortium
author Blackman, Jonathan
author_facet Blackman, Jonathan
Stankeviciute, Laura
Arenaza Urquijo, Eider M.
Suárez Calvet, Marc
Sánchez Benavides, Gonzalo
Vilor Tejedor, Natalia
Iranzo, Alex
Molinuevo, José Luis
Gispert, Juan Domingo
Coulthard, Elizabeth
Grau Rivera, Oriol
European Prevention of Alzheimer’s Disease (EPAD) Consortium
author_role author
author2 Stankeviciute, Laura
Arenaza Urquijo, Eider M.
Suárez Calvet, Marc
Sánchez Benavides, Gonzalo
Vilor Tejedor, Natalia
Iranzo, Alex
Molinuevo, José Luis
Gispert, Juan Domingo
Coulthard, Elizabeth
Grau Rivera, Oriol
European Prevention of Alzheimer’s Disease (EPAD) Consortium
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Programes de prevenció
Malaltia d'Alzheimer
Trastorns del son
Marcadors bioquímics
Prevention programs
Alzheimer's disease
Sleep disorders
Biochemical markers
topic Programes de prevenció
Malaltia d'Alzheimer
Trastorns del son
Marcadors bioquímics
Prevention programs
Alzheimer's disease
Sleep disorders
Biochemical markers
description Sleep abnormalities are prevalent in Alzheimer's disease, with sleep quality already impaired at its preclinical stage. Epidemiological and experimental data point to sleep abnormalities contributing to the risk of Alzheimer's disease. However, previous studies are limited by either a lack of Alzheimer's disease biomarkers, reduced sample size or cross-sectional design. Understanding if, when, and how poor sleep contributes to Alzheimer's disease progression is important so that therapies can be targeted to the right phase of the disease. Using the largest cohort to date, the European Prevention of Alzheimer's Dementia Longitudinal Cohort Study, we test the hypotheses that poor sleep is associated with core Alzheimer's disease CSF biomarkers cross-sectionally and predicts future increments of Alzheimer's disease pathology in people without identifiable symptoms of Alzheimer's disease at baseline. This study included 1168 adults aged over 50 years with CSF core Alzheimer's disease biomarkers (total tau, phosphorylated tau and amyloid-beta), cognitive performance, and sleep quality (Pittsburgh sleep quality index questionnaire) data. We used multivariate linear regressions to analyse associations between core Alzheimer's disease biomarkers and the following Pittsburgh sleep quality index measures: total score of sleep quality, binarized score (poor sleep categorized as Pittsburgh sleep quality index > 5), sleep latency, duration, efficiency and disturbance. On a subsample of 332 participants with CSF taken at baseline and after an average period of 1.5 years, we assessed the effect of baseline sleep quality on change in Alzheimer's disease biomarkers over time. Cross-sectional analyses revealed that poor sleep quality (Pittsburgh sleep quality index total > 5) was significantly associated with higher CSF t-tau; shorter sleep duration (<7 h) was associated with higher CSF p-tau and t-tau; and a higher degree of sleep disturbance (1-9 versus 0 and >9 versus 0) was associated with lower CSF amyloid-beta. Longitudinal analyses showed that greater sleep disturbances (1-9 versus 0 and >9 versus 0) were associated with a decrease in CSF Aβ42 over time. This study demonstrates that self-reported poor sleep quality is associated with greater Alzheimer's disease-related pathology in cognitively unimpaired individuals, with longitudinal results further strengthening the hypothesis that disrupted sleep may represent a risk factor for Alzheimer's disease. This highlights the need for future work to test the efficacy of preventive practices, designed to improve sleep at pre-symptomatic stages of disease, on reducing Alzheimer's disease pathology.
publishDate 2022
dc.date.none.fl_str_mv 2022
2024
2024
2024
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/209366
url https://hdl.handle.net/2445/209366
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Reproducció del document publicat a: https://doi.org/10.1093/braincomms/fcac257
Brain Communications, 2022, vol. 4, num.6
https://doi.org/10.1093/braincomms/fcac257
dc.rights.none.fl_str_mv cc-by (c) Jonathan Blackman et al., 2022
http://creativecommons.org/licenses/by/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv cc-by (c) Jonathan Blackman et al., 2022
http://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 13 p.
application/pdf
dc.publisher.none.fl_str_mv Oxford University Press
publisher.none.fl_str_mv Oxford University Press
dc.source.none.fl_str_mv Articles publicats en revistes (Medicina)
reponame:Recercat. Dipósit de la Recerca de Catalunya
instname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
instname_str Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
reponame_str Recercat. Dipósit de la Recerca de Catalunya
collection Recercat. Dipósit de la Recerca de Catalunya
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869404377464176640
score 15,812455